Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture or Chuna Manual Therapy with Pregabalin for Chemotherapy-Induced Peripheral Neuropathy
KCT0004217Phase 3Recruiting
- Sponsor
- Korea Health Industry Development Institute
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in chemotherapy-induced peripheral neuropathy (CIPN), peripheral neuropathy (CIPN), taxane-induced peripheral neuropathy (TIPN), sponsored by Korea Health Industry Development Institute. Started Nov 2018; status: recruiting.
02
Drugs
pregabalin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)peripheral neuropathy (CIPN)taxane-induced peripheral neuropathy (TIPN)
Beyond the preview
Go deeper on KCT0004217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004217.